New research suggests the HPV vaccine is preventing cancer in men, as well as in women, but fewer boys than girls are getting the shots in the United States....
Palo Alto, California-based biotechnology company Guardant Health has applied for US Food and Drug Administration approval of Shield, its blood test to screen for early signs of colorectal cancer, and on Thursday, a panel of expert advisers to the FDA gathered to discuss data on...
Both recruitment and retention can be improved by making small changes to techniques and implementing cost-effective methods to reduce barriers and make participants feel more included in the overall research process....
The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer....
With a history of precision manufacturing, a thriving talent pool and high quality of life, Wisconsin has established itself as a biohealth hub....
There has been a real push among the industry to improve diversity in trials. The FDA report shows diversity statistics from US trials....
The University of Wisconsin Carbone Cancer Center is now home to the Initiative for Theranostics and Particle Therapy....
Epic is rolling out a new personalized care data tool, which aims to give doctors crucial patient insights. ...
Insist on proper care, ask critical questions about treatments, and push firmly but respectfully for my doctors to truly listen to me as the expert on my own condition. No one understands what a patient is going through better than the patient themselves....
Participation in cancer treatment clinical trials was higher than historical estimates, according to a national sample of data from the Commission on Cancer....
